Risk of Lung Cancer in Peripheral Pulmonary Nodules

Purpose

To determine the risk of lung cancer and inter-observer agreement for small pulmonary nodules either touching or near the pleura.

Methods

Nodules were derived from two cohorts: patients from the National Lung Screening Trial with a solid nodule measuring 6–9.5 mm; and patients with incidental pulmonary nodules in our healthcare system with a solid nodule measuring 1–8 mm. Only the dominant nodule was evaluated for each patient. All malignant nodules as well as a random sample of 200 benign nodules from each cohort were included. Two fellowship-trained thoracic radiologists independently reviewed each case to record nodule morphology (compatible with lymph node or not) and nodule location (pleural-based, septal connection to the pleura, or neither). One radiologist measured the distance to the pleura.

Results

After exclusion criteria were applied, a total of 434 nodules were included, of which 45 were lung cancers. Considering all pleural-based nodules with lymph node morphology as benign, 0–7% of cancers were misclassified as benign, specificity 33%, and κ = 0.69. Considering subpleural nodules and those with septal connection to the pleura, 7–11% of cancers were misclassified (p = 0.16–0.25 versus pleural-based), specificity 40–52% (p < .0001), and κ = 0.60. Considering nodules with lymph node morphology ≤ 2 mm from the pleura, 2–7% of cancers were misclassified (p = 1 versus pleural-based), specificity 41–36% (p < .0001), and κ = 0.78.

Conclusion

Considering nodules with lymph node morphology with septal connection, or those ≤ 2 mm from the pleura, as benign does not lead to significant misclassification of lung cancers as benign.